Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A Case Report of a Keratoacanthoma of the Lip in a Pediatric Patient and Narrative Review.
Ear Nose Throat J
October 2024
Department of Stomatology, New Century Women's and Children's Hospital, Qingdao, Shandong, China.
Keratoacanthoma (KA) is a self-regressing cutaneous tumor sharing clinical and histopathological similarities with squamous cell carcinoma. It is relatively uncommon and presents diagnostic challenges, particularly in pediatric patients. This paper presents a case study of KA affecting the upper lip keratosis in a 6-year-old girl.
View Article and Find Full Text PDFNITROSAMINE CONTAMINATION WITHIN CARDIAC MULTIMEDICATION - SARTANS (VALSARTAN), CALCIUM CHANNEL BLOCKERS (AMLODIPINE AND NIFEDIPINE), AND ANTIARRHYTHMICS (PROPAFENONE) AS A SIGNIFICANT FACTOR IN THE DEVELOPMENT AND PROGRESSION OF MULTIPLE KERATINOCYTIC CANCERS: ADVANCEMENT ROTATION FLAP FOR KERATOACANTHOMA OF THE UPPER LIP AND UNDERMINING SURGERY FOR BCC OF THE SHOULDER AS AN OPTIMAL DERMATOSURGICAL APPROACH.
Georgian Med News
September 2023
Onkoderma - Clinic for Dermatology, Venereology and Dermatologic Surgery, Sofia; Department of Dermatology and Venereology, Medical Institute of Ministry of Interior, Sofia, Bulgaria.
The data on the polycontamination of multimedication in polymorbid patients with a heterogeneous class of carcinogens/nitrosamines, NDSRIs (classified according to the FDA regulation to the companies of 2023 to those with a carcinogenic potency between 1 and 5), are one of the most important steps to clarify the concept of skin cancer nitrosogenesis/ pathogenesis. The FDA is the first regulatory institution in the world to courageously declare that a problem exists and should be addressed. The main and currently unexplained and somewhat controversial issue lies in 1) the sporadic nature of polycontamination in different geographical regions, and 2) the lack of official data from the established international, but also regional pharmaceutical market regulators on the results of the checks conducted for nitrosamine contamination of the respective batches.
View Article and Find Full Text PDFAdverse reactions to the injection of face and neck aesthetic filling materials: a systematic review.
Med Oral Patol Oral Cir Bucal
May 2023
School of Dentistry, University of Campinas 13414-018, Piracicaba, São Paulo, Brazil
Background: Adverse reactions, caused during the inflammation and healing process, or even later, can be induced by the injection of dermal filler and can present a variety of clinical and histological characteristics. In this study we aimed to review the adverse reactions associated with the injection of aesthetic filling materials in the face and neck.
Material And Methods: The review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist.
Interventional treatment of keratoacanthoderma: a case report.
J Int Med Res
December 2022
Department of Interventional Therapy, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, China.
This current case report describes a 56-year-old male patient with a skin mass on his lip that had been growing for 1 year. The pathological findings demonstrated that the epidermis was characterized by hyperkeratosis, hyperplasia and hypertrophy and was formed in the shape of a crater. The skin on both ends had developed into a ball-like growth that resembled a volcanic cone.
View Article and Find Full Text PDFLower lip recurrent keratoacanthoma: A case report.
World J Clin Cases
July 2022
Department of Oral and Maxillofacial Surgery, Shandong University, Jinan 250100, Shandong Province, China.
Background: This paper introduces a case of recurrent keratoacanthoma (KA). KA is a self-healing disease. Recurrence after surgical resection is rare.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!